Dr. Hani GabraBSc MB ChB MSc PhD FRCPE FRCPProfessor of Medical OncologyCancer Imperial College London
Hani Gabra is Professor of Medical Oncology, Head of the Molecular Therapeutics Unit and Deputy Head of the Division of Cancer at Imperial College London. He is Director of the Ovarian Cancer Action Research Centre at the Hammersmith Campus of Imperial College and is also Honorary Consultant Medical Oncologist and Lead Clinician for Cancer Clinical Trials at Imperial College Healthcare NHS Trust.
Hani graduated from the University of Glasgow Medical School and did his postgraduate clinical training in Edinburgh and PhD at the MRC Human Genetics Unit, University of Edinburgh and was CRUK Clinical Scientist and Consultant in Medical Oncology in Edinburgh 1998-2003.
His basic research interests are in ovarian cancer tumour suppressor genes, his group having identified the OPCML and the WWOX tumour-suppressor genes, and cancer multiplatform molecular profiling and integrative OMICS. He has translational research interests in the molecular basis of clinical platinum resistance, and the molecular basis of locoregional peritoneal dissemination in ovarian cancer, as well as all phases of clinical research.
He was the first Chief of Service of the West London Gynaecological Cancer Centre 2003-2008 and was Strategic Theme Leader for Cancer at Imperial 2004-2007.
Between 2004-2009 Hani led the Scottish Gynaecological Cancer Trials Group (SCOTROC) Ovarian Cancer Section and was the Scottish Group’s representative to the Gynaecological Cancer Intergroup.
He is a founding President of the European Translational Ovarian Cancer Network (EUTROC), and is a member of several international consortia of ovarian cancer molecular profiling.